FDA Inspection 1313642 — Resoundant Inc.
The FDA completed an inspection of Resoundant Inc. on Apr 15, 2026 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 15, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Rochester, MN (United States)